Cytosorbents Corporation Revenue 2011–2025
Cytosorbents Corporation annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Cytosorbents Corporation revenue for the quarter ending March 31, 2026 was 8.9 M, a 1.57% increase year-over-year.
- Cytosorbents Corporation revenue for the twelve months ending March 31, 2026 was 36.7 M, a 4.08% increase year-over-year.
- Cytosorbents Corporation annual revenue for 2025 was 37.1 M, a 4.12% increase from 2024.
- Cytosorbents Corporation annual revenue for 2024 was 35.6 M, a 14.51% increase from 2023.
- Cytosorbents Corporation annual revenue for 2023 was 31.1 M, a 10.39% decrease from 2022.
- Cytosorbents Corporation annual revenue for 2022 was 34.7 M.
Cytosorbents Corporation (CTSO) — Frequently Asked Questions
Cytosorbents Corporation (CTSO) is a publicly traded US company. It has a market capitalization of $24M. In fiscal 2025 it reported revenue of $37M and net income of -$8M. Explore CTSO's stock price, financial statements, earnings history, margins and key ratios below.
What is Cytosorbents Corporation's market cap?
Cytosorbents Corporation (CTSO) has a market capitalization of $24M.
What is the CTSO stock price?
CTSO trades at $0.38 (-7.52% on the day).
How much revenue does Cytosorbents Corporation make?
Cytosorbents Corporation reported revenue of $37M in fiscal 2025.
Is CTSO profitable?
In fiscal 2025, Cytosorbents Corporation reported net income of -$8M.